Clinical Nutrition Research

  • 제12권1호
  • /
  • Pages.77-89
  • /
  • 2023
  • /
  • 2287-3732(pISSN)
  • /
  • 2287-3740(eISSN)
한국임상영양학회 (The Korean Society of Clinical Nutrition)
권호 표지
DOI QR코드

DOI QR Code

The Role of Some Vitamins in Respiratory-related Viral Infections: A Narrative Review

  • Jae-Hee Park (Department of Food and Nutrition, Kyungnam University) ;
  • Yunjung Lee (Department of Food and Nutrition, Kyungnam University) ;
  • Mijoo Choi (Department of Food and Nutrition, Kyungnam University) ;
  • Eunju Park (Department of Food and Nutrition, Kyungnam University)
  • 투고 : 2023.01.12
  • 심사 : 2023.01.25
  • 발행 : 2023.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study aimed to find out the effect of vitamins on respiratory-related viral infections, including coronavirus disease 2019 (COVID-19), through the literature reviews. From January 2000 to June 2021, the studies (cohort studies, cross-sectional studies, case-control studies, randomized control trials) related to vitamins (vitamin A, D, E, C, B6, folate, and B12) and COVID-19/severe acute respiratory syndrome/Middle East respiratory syndrome/cold/influenza were selected from the PubMed, Embase, and Cochrane libraries and analyzed. The relationship between vitamins and virus-related respiratory diseases was identified. Through the review, 39 studies were selected on vitamin D, one study on vitamin E, 11 studies on vitamin C, and 3 studies on folate. Regarding COVID-19, 18 studies on vitamin D, 4 studies on vitamin C, and 2 studies on folate showed significant effects of the intake of these nutrients in preventing COVID-19. Regarding colds and influenza, 3 studies on vitamin D, 1 study on vitamin E, 3 studies on vitamin C, and 1 study on folate demonstrated that the intake of these nutrients significantly prevents these diseases. Therefore, this review suggested the intake of vitamins D, E, C, and folate is important for preventing respiratory diseases related to viruses, such as COVID-19, colds, and influenza. The relationship between these nutrients and virus-related respiratory diseases should be continuously monitored in the future.

키워드

과제정보

This work was supported by the Amway corporation.

참고문헌

  1. Rising D. Death toll nears 6 million as pandemic enters its 3rd year [Internet]. Available from https://apnews.com/article/russia-ukraine-coronavirus-pandemic-science-business-health-69e8cbaebb653a0f1cb65ffe33d9afbd [cited 2022 March 7]. 2002. 
  2. Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Cureus 2020;12:e7423.
  3. Duffy S. Why are RNA virus mutation rates so damn high? PLoS Biol 2018;16:e3000003.
  4. Hui DS, Azhar EI, Memish ZA, Zumla A. Human coronavirus infections-severe acute respiratory syndrome (SARS), middle east respiratory syndrome (MERS), and SARS-CoV-2. In: Janes SM, editor. Encyclopedia of Respiratory Medicine. Amsterdam: Elsevier; 2022. p. 146-61. 
  5. BourBour F, Mirzaei Dahka S, Gholamalizadeh M, Akbari ME, Shadnoush M, Haghighi M, Taghvaye-Masoumi H, Ashoori N, Doaei S. Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus. Arch Physiol Biochem 2020.
  6. Calder PC, Carr AC, Gombart AF, Eggersdorfer M. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients 2020;12:1181.
  7. Baktash V, Hosack T, Patel N, Shah S, Kandiah P, Van den Abbeele K, Mandal AK, Missouris CG. Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J 2021;97:442-7.
  8. D'Avolio A, Avataneo V, Manca A, Cusato J, De Nicolo A, Lucchini R, Keller F, Cantu M. 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients 2020;12:1359.
  9. Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open 2020;3:e2019722.
  10. Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S, De Stefano L, Bruno R, Corsico AG, Di Sabatino A, Perlini S, Montecucco C, Caccialanza R; NUTRI-COVID19 IRCCS San Matteo Pavia Collaborative Group. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin Nutr 2021;40:2469-72.
  11. Gavioli EM, Miyashita H, Hassaneen O, Siau E. An evaluation of serum 25-hydroxy vitamin D levels in patients with COVID-19 in New York city. J Am Nutr Assoc 2022;41:201-6.
  12. Hastie CE, Pell JP, Sattar N. Vitamin D and COVID-19 infection and mortality in UK Biobank. Eur J Nutr 2021;60:545-8.
  13. Infante M, Buoso A, Pieri M, Lupisella S, Nuccetelli M, Bernardini S, Fabbri A, Iannetta M, Andreoni M, Colizzi V, Morello M. Low vitamin D status at admission as a risk factor for poor survival in hospitalized patients with COVID-19: an Italian retrospective study. J Am Nutr Assoc 2022;41:250-65.
  14. Lohia P, Nguyen P, Patel N, Kapur S. Exploring the link between vitamin D and clinical outcomes in COVID-19. Am J Physiol Endocrinol Metab 2021;320:E520-6.
  15. Orchard L, Baldry M, Nasim-Mohi M, Monck C, Saeed K, Grocott MP, Ahilanandan D. Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients. Clin Chem Lab Med 2021;59:1155-63.
  16. Osman W, Al Fahdi F, Al Salmi I, Al Khalili H, Gokhale A, Khamis F. Serum calcium and vitamin D levels: correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman. Int J Infect Dis 2021;107:153-63.
  17. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010;5:e11088.
  18. Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 2011;106:1433-40.
  19. Brenner H, Holleczek B, Schottker B. Vitamin D insufficiency and deficiency and mortality from respiratory diseases in a cohort of older adults: potential for limiting the death toll during and beyond the COVID-19 pandemic? Nutrients 2020;12:2488.
  20. Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi-Newton S, Kong MF, Jude EB. High-dose cholecalciferol booster therapy is associated with a reduced risk of mortality in patients with COVID-19: a cross-sectional multi-centre observational study. Nutrients 2020;12:3799.
  21. Abdollahi H, Salehinia F, Badeli M, Karimi E, Gandomkar H, Asadollahi A, Sedighiyan M, Abdolahi M. The biochemical parameters and vitamin D Levels in ICU patients with COVID-19: a cross-sectional Study. Endocr Metab Immune Disord Drug Targets 2021;21:2191-202.
  22. De Smet D, De Smet K, Herroelen P, Gryspeerdt S, Martens GA. Serum 25(OH)D level on hospital admission associated with COVID-19 stage and mortality. Am J Clin Pathol 2021;155:381-8.
  23. Katz J, Yue S, Xue W. Increased risk for COVID-19 in patients with vitamin D deficiency. Nutrition 2021;84:111106.
  24. Luo X, Liao Q, Shen Y, Li H, Cheng L. Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people. J Nutr 2021;151:98-103.
  25. Nasiri M, Khodadadi J, Molaei S. Does vitamin D serum level affect prognosis of COVID-19 patients? Int J Infect Dis 2021;107:264-7.
  26. Meoli M, Muggli F, Lava SA, Bianchetti MG, Agostoni C, Kocher C, Buhrer TW, Ciliberti L, Simonetti GD, Milani GP. Status in adolescents during COVID-19 pandemic: a cross-sectional comparative study. Nutrients 2021;13:1467.
  27. Pugach IZ, Pugach S. Strong correlation between prevalence of severe vitamin D deficiency and population mortality rate from COVID-19 in Europe. Wien Klin Wochenschr 2021;133:403-5.
  28. Yadav D, Birdi A, Tomo S, Charan J, Bhardwaj P, Sharma P. Association of vitamin D status with COVID-19 infection and mortality in the Asia pacific region: a cross-sectional study. Indian J Clin Biochem 2021;36:492-7.
  29. Pletz MW, Terkamp C, Schumacher U, Rohde G, Schutte H, Welte T, Bals R; CAPNETZ-Study Group. Vitamin D deficiency in community-acquired pneumonia: low levels of 1,25(OH)2 D are associated with disease severity. Respir Res 2014;15:53.
  30. Rafiq R, Thijs W, Prein R, de Jongh RT, Taube C, Hiemstra PS, de Mutsert R, den Heijer M. Associations of serum 25(OH)D concentrations with lung function, airway inflammation and common cold in the general population. Nutrients 2018;10:35.
  31. Abdollahi A, Kamali Sarvestani H, Rafat Z, Ghaderkhani S, Mahmoudi-Aliabadi M, Jafarzadeh B, Mehrtash V. The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID-19 infection: a case-control study of hospitalized patients in Tehran, Iran. J Med Virol 2021;93:2359-64.
  32. Al-Daghri NM, Amer OE, Alotaibi NH, Aldisi DA, Enani MA, Sheshah E, Aljohani NJ, Alshingetti N, Alomar SY, Alfawaz H, Hussain SD, Alnaami AM, Sabico S. Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection: a multi-centre case-control study. J Transl Med 2021;19:166.
  33. Alguwaihes AM, Sabico S, Hasanato R, Al-Sofiani ME, Megdad M, Albader SS, Alsari MH, Alelayan A, Alyusuf EY, Alzahrani SH, Al-Daghri NM, Jammah AA. Severe vitamin D deficiency is not related to SARS-CoV-2 infection but may increase mortality risk in hospitalized adults: a retrospective case-control study in an Arab Gulf country. Aging Clin Exp Res 2021;33:1415-22.
  34. Hernandez JL, Nan D, Fernandez-Ayala M, Garcia-Unzueta M, Hernandez-Hernandez MA, Lopez-Hoyos M, Munoz-Cacho P, Olmos JM, Gutierrez-Cuadra M, Ruiz-Cubillan JJ, Crespo J, Martinez-Taboada VM. Vitamin D status in hospitalized patients with SARS-CoV-2 Infection. J Clin Endocrinol Metab 2021;106:e1343-53.
  35. Ye K, Tang F, Liao X, Shaw BA, Deng M, Huang G, Qin Z, Peng X, Xiao H, Chen C, Liu X, Ning L, Wang B, Tang N, Li M, Xu F, Lin S, Yang J. Does serum vitamin D level affect COVID-19 infection and its severity?-a case-control study. J Am Coll Nutr 2021;40:724-31.
  36. Nanri A, Nakamoto K, Sakamoto N, Imai T, Akter S, Nonaka D, Mizoue T. Association of serum 25-hydroxyvitamin D with influenza in case-control study nested in a cohort of Japanese employees. Clin Nutr 2017;36:1288-93.
  37. Rastogi A, Bhansali A, Khare N, Suri V, Yaddanapudi N, Sachdeva N, Puri GD, Malhotra P. Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J 2022;98:87-90.
  38. Ohaegbulam KC, Swalih M, Patel P, Smith MA, Perrin R. Vitamin D supplementation in COVID-19 patients: a clinical case series. Am J Ther 2020;27:e485-90.
  39. Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CS, Silva CB, Franco AS, Macedo MB, Dalmolin HH, Baggio J, Balbi GG, Reis BZ, Antonangelo L, Caparbo VF, Gualano B, Pereira RM. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial. JAMA 2021;325:1053-60.
  40. Rees JR, Hendricks K, Barry EL, Peacock JL, Mott LA, Sandler RS, Bresalier RS, Goodman M, Bostick RM, Baron JA. Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clin Infect Dis 2013;57:1384-92.
  41. Aglipay M, Birken CS, Parkin PC, Loeb MB, Thorpe K, Chen Y, Laupacis A, Mamdani M, Macarthur C, Hoch JS, Mazzulli T, Maguire JL; TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA 2017;318:245-54.
  42. Shimizu Y, Ito Y, Yui K, Egawa K, Orimo H. Intake of 25-hydroxyvitamin D3 reduces duration and severity of upper respiratory tract infection: a randomized, double-blind, placebo-controlled, parallel group comparison study. J Nutr Health Aging 2018;22:491-500.
  43. Loeb M, Dang AD, Thiem VD, Thanabalan V, Wang B, Nguyen NB, Tran HT, Luong TM, Singh P, Smieja M, Maguire J, Pullenayegum E. Effect of vitamin D supplementation to reduce respiratory infections in children and adolescents in Vietnam: a randomized controlled trial. Influenza Other Respi Viruses 2019;13:176-83.
  44. Urashima M, Mezawa H, Noya M, Camargo CA Jr. Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: a randomized controlled trial. Food Funct 2014;5:2365-70.
  45. Zhou J, Du J, Huang L, Wang Y, Shi Y, Lin H. Preventive effects of vitamin D on seasonal influenza A in infants: a multicenter, randomized, open, controlled clinical trial. Pediatr Infect Dis J 2018;37:749-54.
  46. Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, Hamer DH. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 2004;292:828-36.
  47. Xing Y, Zhao B, Yin L, Guo M, Shi H, Zhu Z, Zhang L, He J, Ling Y, Gao M, Lu H, Mao E, Zhang L. Vitamin C supplementation is necessary for patients with coronavirus disease: an ultra-high-performance liquid chromatography-tandem mass spectrometry finding. J Pharm Biomed Anal 2021;196:113927.
  48. Zhao B, Ling Y, Li J, Peng Y, Huang J, Wang Y, Qu H, Gao Y, Li Y, Hu B, Lu S, Lu H, Zhang W, Mao E. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study. Ann Palliat Med 2021;10:1599-609.
  49. Zhao B, Liu M, Liu P, Peng Y, Huang J, Li M, Wang Y, Xu L, Sun S, Qi X, Ling Y, Li J, Zhang W, Mao E, Qu J. Qu. High dose intravenous vitamin C for preventing the disease aggravation of moderate COVID-19 pneumonia. A retrospective propensity matched before-after study. Front Pharmacol 2021;12:638556.
  50. Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, Luo G, Meng Z, De Backer D, Xiang H, Peng Z. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care 2021;11:5.
  51. Thomas S, Patel D, Bittel B, Wolski K, Wang Q, Kumar A, Il'Giovine ZJ, Mehra R, McWilliams C, Nissen SE, Desai MY. Effect of high-dose zinc and ascorbic acid supplementation vs usual care on symptom length and reduction among ambulatory patients with SARS-CoV-2 infection: the COVID A to Z randomized clinical Trial. JAMA Netw Open 2021;4:e210369.
  52. Kumari P, Dembra S, Dembra P, Bhawna F, Gul A, Ali B, Sohail H, Kumar B, Memon MK, Rizwan A. The role of vitamin C as adjuvant therapy in COVID-19. Cureus 2020;12:e11779.
  53. Audera C, Patulny RV, Sander BH, Douglas RM. Mega-dose vitamin C in treatment of the common cold: a randomised controlled trial. Med J Aust 2001;175:359-62.
  54. Van Straten M, Josling P. Preventing the common cold with a vitamin C supplement: a double-blind, placebo-controlled survey. Adv Ther 2002;19:151-9.
  55. Sasazuki S, Sasaki S, Tsubono Y, Okubo S, Hayashi M, Tsugane S. Effect of vitamin C on common cold: randomized controlled trial. Eur J Clin Nutr 2006;60:9-17.
  56. Johnston CS, Barkyoumb GM, Schumacher SS. Vitamin C supplementation slightly improves physical activity levels and reduces cold incidence in men with marginal vitamin C status: a randomized controlled trial. Nutrients 2014;6:2572-83.
  57. Kim TK, Lim HR, Byun JS. Vitamin C supplementation reduces the odds of developing a common cold in Republic of Korea Army recruits: randomised controlled trial. BMJ Mil Health 2022;168:117-23.
  58. Acosta-Elias J, Espinosa-Tanguma R. The folate concentration and/or folic acid metabolites in plasma as factor for COVID-19 infection. Front Pharmacol 2020;11:1062.
  59. Hamer DH, Sempertegui F, Estrella B, Tucker KL, Rodriguez A, Egas J, Dallal GE, Selhub J, Griffiths JK, Meydani SN. Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians. J Nutr 2009;139:113-9.
  60. Itelman E, Wasserstrum Y, Segev A, Avaky C, Negru L, Cohen D, Turpashvili N, Anani S, Zilber E, Lasman N, Athamna A, Segal O, Halevy T, Sabiner Y, Donin Y, Abraham L, Berdugo E, Zarka A, Greidinger D, Agbaria M, Kitany N, Katorza E, Shenhav-Saltzman G, Segal G. Clinical characterization of 162 COVID-19 patients in Israel: preliminary report from a large tertiary center. Isr Med Assoc J 2020;22:271-4.